Author/Authors :
Safari، Zohreh نويسنده Univeristy of Najafabad , , Safaralizadeh، Reza نويسنده Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran Safaralizadeh, Reza , Seyedzadeh، Mir Hadi نويسنده Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran Seyedzadeh, Mir Hadi , Valinezad Orang، Ayla نويسنده Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran Valinezad Orang, Ayla , Zare، Ahad نويسنده Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran Zare, Ahad , Hosseinpour Feizi، Mohammad Ali نويسنده Department of Biology, Faculty of Natural science, University of Tabriz, Tabriz, IR Iran , , Kardar، Gholam Ali نويسنده ,
Abstract :
It is aimed to evaluate the actual anti-cancerous effects of metformin on cancer cells in hypoxic condition. Non-cancerous cells (HEK293) and cancer cells (MCF-7) were cultured in both hypoxia and normoxia conditions and treated with different concentrations of metformin. The proliferation, apoptosis, and necrosis rate were assessed using MTT test and Annexin V assay. The S6K1 phosphorylation was assessed using western blotting. Zymography was used to measure the activity of metalloproteinase-9 (MMP-9). Metformin treatment inhibited proliferation of cancer cells in the optimal concentration of 10 mM under hypoxia condition, while it showed no effects on non-cancerous cell viability. The statistical analysis of MTT assay indicated that the pro-apoptotic function of metformin for cancer cells under hypoxia condition compared to normoxia was significant with different metformin concentrations (p<0.01). However, the effect of metformin treatments for non-cancerous cells under hypoxia condition compared to normoxia was not significant. Western-blot analysis indicated a significant decrease in S6K1 phosphorylation in cancer cells under hypoxia condition (p<0.05). Nevertheless, there was no considerable difference between normoxia and hypoxia conditions in non-cancerous cells. MMP-9 zymography analysis revealed that the highest inhibition of MMP-9 activity was observed in hypoxia condition by 20mM of metformin concentration only in cancer cell. The results indicate that in hypoxia condition metformin exerts its anti-cancerous function by inhibiting proliferation and tumor progression and inducing cell apoptosis more effectively than normoxia condition. In line with cancer cell conditions, most importantly hypoxic condition, metformin can be considered as a potential anti-cancerous drug.
